DAS
ARCT icon

Diversify Advisory Services’s Arcturus Therapeutics ARCT Stock Holding History

Diversify Advisory Services’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-115,500
Closed -$13.1K – 915
2025
Q3 		$13.1K Buy
+115,500
New +$1.86M ﹤0.01% 870

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Diversify Advisory Services's ARCT Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 15,785 shares worth $90.9K. The stake represents ﹤0.01% of the portfolio and ranks #1226 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in ARCT as recently as Q4 2025.

Diversify Advisory Services first reported a position in ARCT in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.31M in Q2 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Diversify Advisory Services held 15,785 shares of Arcturus Therapeutics worth $90.9K as of Q2 2026.
  • Arcturus Therapeutics was a new Diversify Advisory Services position in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Diversify Advisory Services's portfolio in Q2 2026, its #1226 holding.
  • Diversify Advisory Services first reported a position in Arcturus Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Diversify Advisory Services's Arcturus Therapeutics position peaked at $3.31M in Q2 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.